SCHEMBL11791027

SCHEMBL11791027

C=C(CC(=O)O)C(=O)N(CC)CC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
ALDH2 P05091 2/20 0.42
HSD17B10 Q99714 3/20 0.40
ALOX15 P16050 2/20 0.40
LDHA P00338 1/20 0.35
SRR Q9GZT4 1/20 0.35
LMNA P02545 2/20 0.34
RAB9A P51151 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
FFAR3 O14843 1/20 0.33
MMP1 P03956 1/20 0.33
MMP2 P08253 1/20 0.33
MMP3 P08254 1/20 0.33
MMP8 P22894 1/20 0.33
NPC1 O15118 2/20 0.33
EGFR P00533 1/20 0.32
KDM4E B2RXH2 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
KMT2A Q03164 3/20 0.32
MEN1 O00255 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11523442 0.78 LMNA (0.39) ALDH1A1ALDH2HSD17B10ALOX15LMNA
SCHEMBL8832223 0.77 ALDH1A1 (0.43) ALDH1A1ALDH2HSD17B10ALOX15LMNA
SCHEMBL19359715 0.76 LMNA (0.37) ALDH1A1ALDH2HSD17B10ALOX15LMNA
SCHEMBL5282080 0.76 ALOX15 (0.43) HSD17B10ALOX15LDHASRRFFAR3
SCHEMBL1738956 0.75 LMNA (0.40) ALDH1A1ALDH2HSD17B10ALOX15LMNA
SCHEMBL17284806 0.75 ALOX15 (0.35) HSD17B10ALOX15KMT2A
SCHEMBL11243264 0.74 LMNA (0.52) ALDH1A1ALDH2HSD17B10ALOX15LMNA
SCHEMBL1629859 0.74 LMNA (0.41) ALDH1A1ALDH2HSD17B10ALOX15LMNA
SCHEMBL4976102 0.74 LMNA (0.36) ALDH1A1ALDH2HSD17B10ALOX15LMNA
SCHEMBL14252726 0.74 ALOX15 (0.52) ALDH1A1HSD17B10ALOX15LDHASRR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180066113-A9 AMINOSILOXANE POLYMER AND METHOD OF FORMING DOW SILICONES CORPORATION 2018-03-08 US disclosed
US-20170096533-A1 AMINOSILOXANE POLYMER AND METHOD OF FORMING DOW CORNING (US) 2017-04-06 US disclosed
US-4000358-A ACRYLIC POLYMERSAMIDE ALELIO GAETANO F D 1976-12-28 US disclosed
US-3950392-A FIREPROOFING, HOMOPOLYMERIZATION, COPOLYMERIZATION ALELIO GAETANO F D 1976-04-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180066113-A9 AMINOSILOXANE POLYMER AND METHOD OF FORMING HRH3, H1-2, H1-0 ALDH1A1 1927/4885ALDH2 4205/4885HSD17B10 476/4885
US-20170096533-A1 AMINOSILOXANE POLYMER AND METHOD OF FORMING HRH3, H1-2, H1-0 ALDH1A1 1927/4885ALDH2 4205/4885HSD17B10 476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.